Virusight Diagnostic, an Israeli company that combines artificial intelligence software and spectral technology announced the results of a study that found that its Pathogens Diagnostic device detects COVID-19 with 96.3 percent accuracy in comparison to the common RT-PCR.
The study was conducted by researchers from the Department of Science and Technology, University of Sannio, Benevento, Italy with partner company TechnoGenetics S.p. A.
The Virusight solution was tested on 550 saliva samples and found to be safe and effective.
Comments are closed.